Stock Analysis on Net

Moderna Inc. (NASDAQ:MRNA)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 7, 2024.

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Moderna Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Accounts payable
Accrued liabilities
Deferred revenue
Income taxes payable
Other current liabilities
Current liabilities
Deferred revenue, non-current
Operating lease liabilities, non-current
Financing lease liabilities, non-current
Deferred lease obligation, non-current
Lease financing obligation
Other non-current liabilities
Non-current liabilities
Total liabilities
Preferred stock, par value $0.0001; no shares issued or outstanding
Common stock, par value $0.0001
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Current liabilities
Current liabilities show significant volatility over the analyzed periods. Starting at a low base in early 2019, there is a marked increase during 2020, peaking in the fourth quarter of 2021. This surge is largely attributable to substantial increases in accrued liabilities, deferred revenue, and accounts payable during this timeframe. After reaching a peak, current liabilities decline notably through 2023 and into the first half of 2024.
Accounts payable
Accounts payable remain relatively low and stable through 2019, with minor fluctuations. A sharp upward trend begins in 2021, reaching a high in late 2022 of 487 million USD, followed by some volatility and a decrease in mid-2024. This indicates increased short-term obligations to suppliers or vendors during the peak years.
Accrued liabilities
Accrued liabilities display a pronounced rising trend starting in mid-2020, peaking at 2.1 billion USD by the end of 2022. Afterward, the figure decreases steadily into 2023 and remains somewhat elevated but declining through mid-2024. This pattern reflects increasing expenses incurred but not yet paid during the peak years, possibly associated with operational scaling or project expenses.
Deferred revenue (current)
Deferred revenue exhibits dramatic growth from mid-2020 through 2021, peaking at nearly 8 billion USD in the third and fourth quarters of 2021. A declining trend follows through 2023 and into 2024. This suggests a surge in prepayments from customers or clients during the earlier periods, likely linked to product or service deliveries, followed by recognition of this revenue in subsequent periods.
Income taxes payable
Income taxes payable data begins only in late 2021 and shows variability with a peak around 1.6 billion USD in the third quarter of 2022, then substantially declining in subsequent quarters to single-digit millions in 2024. This pattern may indicate tax liabilities accumulating due to profitability spikes and subsequent payments or adjustments.
Other current liabilities
Other current liabilities rise sharply from 2019 into 2021, reaching a high of over 600 million USD, followed by a fluctuation and generally declining trend afterward. The data suggests additional short-term obligations increasing with business activity around 2020–2021, then stabilizing.
Non-current liabilities
Non-current liabilities generally increase over the observation period, with a notable rise from 2019 through 2021, topping near 1.8 billion USD by late 2022. Afterwards, non-current liabilities largely stabilize and slightly decline by mid-2024. Financing lease liabilities and operating lease liabilities represent significant components and present increasing trends, especially financing lease liabilities, which peak around late 2022 and remain relatively high.
Total liabilities
Total liabilities show a substantial increase starting in 2020, peaking in late 2021 at over 10.7 billion USD. Thereafter, total liabilities decline steadily through 2023 and 2024, reflecting a reduction in both current and non-current obligations post-peak. This overall pattern suggests a phase of increased financial commitments followed by deleveraging or liability management.
Stockholders’ equity
Stockholders’ equity expands significantly from 2019 through 2021, reaching a peak of over 14 billion USD by the end of 2021. It continues to grow, though at a slower pace, to about 19 billion USD by the end of 2022, before retreating through 2023 and 2024 to approximately 11.9 billion USD. This fluctuation is driven largely by changes in retained earnings, which see dramatic improvement starting in early 2021, transitioning from accumulated deficits to large accumulated earnings, followed by declines.
Retained earnings
Retained earnings were negative and decreasing from 2019 through 2020, indicating losses or deficits accumulating over time. Beginning in early 2021, there is a pronounced reversal with retained earnings sharply increasing to positive values above 18 billion USD in late 2022. Subsequently, retained earnings decline but remain positive through mid-2024. This reflects a period of significant profitability followed by moderate decreases in accumulated earnings.
Accumulated other comprehensive income (loss)
Accumulated other comprehensive income/loss fluctuates mildly between positive and negative values. It is marginally positive during early periods, turns negative from 2021 through most of 2023, and shows slight recovery by mid-2024. The magnitudes remain relatively small compared to the other components and suggest limited impact on total equity.
Additional paid-in capital
Additional paid-in capital rises steadily from 2019 to mid-2021 but then decreases sharply from late 2021 through 2023, followed by modest increases in 2024. This pattern may reflect capital raises or equity transactions in earlier periods with subsequent repurchases, adjustments, or amortizations reducing the balance.
Total liabilities and stockholders’ equity
The total of liabilities and stockholders’ equity expands approximately sevenfold from under 2 billion USD in early 2019 to over 24 billion USD at the end of 2021, indicating substantial growth in the company's asset base or financing activities. After reaching this peak, the total contracts through 2023 and early 2024, aligning with the trends in liabilities and equity changes previously noted.